“One of the biggest challenges in developing new cancer drugs is accessing the large amounts of clinical data you need to make reliable predictions about how the drug will affect a patient’s prognosis,” said James Zou, Chief AI scientist at Stanford Health and senior author of the study.
“Collecting this data in humans is slow and incredibly expensive, but by partnering with veterinarians and their canine patients we can use that clinical data to dramatically accelerate the development of novel cancer treatments that will benefit both dogs and their owners.”
